Political Influences And Regulatory Implications For Biotech In 2025
By Tyler Menichiello, contributing editor
In a perfect world, science is apolitical and remains insulated from the shifting tides of governance. However, the real world is not so simple, and political issues can have a significant impact on the highly regulated biotech industry. From the U.S. election and new presidential appointments to strong bipartisan support of the BIOSECURE Act, there are several political influences likely to impact biotech in the coming years. In this segment from “Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond,” CEO, co-founder, and president of Ossium Health, Kevin Caldwell; CSO of FibroBiologics, Hamid Khoja, Ph.D.; and president and acting CEO of Triumvira Immunologics, Rob Williamson, discuss the changing political landscape and its potential effect on industry from a regulatory and economic point of view.